KUL team participation at conferences in May -June 2024
InnovationActa
American Society of Gene & Cell Therapy
Nick Geukens from the KUL team took part in the American Society of Gene & Cell Therapy 27th Annual Meeting held between 7th and 11th May 2024 in Baltimore, United States
The KUL team presented their work related to unraveling the multifactorial host immune response triggered by intramuscular electrotransfer of a DNA-encoded antibody.
Biotech conference in the Benelux
Members of the KUL team joined in the biggest biotech conference in the BeNeLux, Knowledge for Growth, held between 15th and 16th May 2024 in Antwerpen, Belgium.
“Antigen-Specific Immune Monitoring of T Cells, B Cells, and Non-conventional Immune Cells” Conference
On the 12th of June 2024, Nick Geukens from the KUL team participated in the conference dedicated to “Antigen-Specific Immune Monitoring of T Cells, B Cells, and Nonconventional Immune Cells”. The event was held in Amsterdam, Netherlands.
To view more
American Society of Gene & Cell Therapy
Baltimore – United States
go to the website: https://annualmeeting.asgct.org/
Biotech conference in the BeNeLux
Antwerpen – Belgium
go to the website: https://knowledgeforgrowth.be/
“Antigen-Specific Immune Monitoring of T Cells, B Cells, and Non-conventional Immune Cells” Conference
Amsterdam, Netherlands.
go to the website: https://www.immudex.com/
Jill de Mol receives best presentation award at the Dutch Atherosclerosis Society Symposium 2024
InnovationActa
At the 2024 Dutch Atherosclerosis Society Symposium, held on May 23rd in Zeist, Jill de Mol from the Division of BioTherapeutics received the award for best oral presentation for her work on age-associated B cells in atherosclerosis.
During this annual symposium, organized by the Dutch Atherosclerosis Society board, basic scientists and clinicians present and discuss their recent developments in the field of atherosclerosis research. Almost the entire cardiovascular ULEI lab attended this meeting and contributed to the program. B-specific member Ilze Bot provided the keynote lecture entitled ‘Mast cells as effectors in advanced atherosclerosis’. Amanda Foks presented her research on ‘Sexual dimorphism in atherosclerotic plaques of aged Ldlr deficient mice’ and Jill de Mol presented our progress on age-associated B cells in atherosclerosis in the session of selected abstracts.
LACDR Spring Symposium 2024
InnovationActa
On May 14 2024, Jill represented the Division of BioTherapeutics in the annual LACDR Spring Symposium and presented her research on age-associated B cells in atherosclerosis. The LACDR Spring Symposium is attended by ~150 LACDR employees. In addition, master students of BioPharmaceutical Sciences attend this Symposium to learn about our research and for whom this is a training activity.
Presentation FCVB 12 Aprile 2024
InnovationActa
The ULEI team participated at the European Society of Cardiology: Frontiers in CardioVascular Biomedicine 2024 Congress held in Amsterdam, Netherlands on the 12th– 14th of April 2024.
The ULEI team includes Assoc. Prof. Amanda Foks, Prof. Ilze Bot and the PhD candidate Jill de Mol (photo on the right).
Amanda Foks invited talk was entitled “Age-associated B cell immunity in atherosclerosis”
New PhD students
Welcome to
Kauthar Parker (Kauthar Parker - Leiden University (universiteitleiden.nl))
Anna Witteveen (Anna Witteveen - Leiden University (universiteitleiden.nl))
Jill de Mol (Jill de Mol - Leiden University (universiteitleiden.nl))
European symposium on controlled drug delivery
InnovationActa
B-specific PI, Assoc. Prof. Bram Slütter was invited to the European Symposium of Controlled Drug Delivery, held between 10th to 12th April at Egmond aan Zee, Netherland. His talk was entitled ‘Platforms for Induction of Antigen Specific Tolerance in Cardiovascular Disease’.
"A crown per heartbeat" in Sweden
InnovationActa
On March 14th, Samuel Andersson from the ULUND team spoke at an event called “en krona per hjärtslag” (“a crown per heartbeat”) in Helsingborg, Sweden. The public event organized by high school students from Johannes Hedberggymnasiet, aimed to raise funds for cardiovascular research by collecting as many Swedish crowns as there are heartbeats in 2 hours (duration of the event).
In his talk entitled “Hjärt-kärlsjukdomar och forskning – en kort historia” (“Cardiovascular diseases and research – a short story”), Samuel discussed the history of cardiovascular research and immunology introducing his PhD research, focusing on studying B cells and their role in atherosclerosis.
Samuel emphasized how the activities at ULUND have contributed to cardiovascular research through SCAPIS, FIMCOD, and other studies that have led to compounds being tested in clinical trials. Overall, the event was a great success, surpassing the original fundraising goal by almost three times.
Photo by Rickard Lindblom
B-specific Coordinator was invited to three important scientific events
InnovationActa
B-specific coordinator Assoc. Prof. Amanda Foks was invited to three important scientific events during February and March 2024, in which she presented data on age-associated immunity, particularly ABCs, in atherosclerosis, including pathophysiology and potential targets for therapy.
She gave talks at
Vascular Medicine and Atherosclerosis Congress 2024, Augsburg, Germany on the 23rd of February;
Danish Academy Winter Meeting 2024, Norefjell, Norway on 29th of February;
Dutch German Joint Meeting of the Molecular Cardiology Working Groups, UMC Groningen, Netherlands on the 15th if March.
Presentation Young PI meeting
InnovationActa
The Young Cardiovascular PI meeting took place on the 24th of January 2024 at Bergeijk, Netherlands. The meeting was attended by B-specific coordinator Assoc. Prof. Amanda Foks (invited) and PhD candidate Jill de Mol. Amanda and Jill presented research on single-cell profiling of age-associated B-cell immunity in atherosclerosis.
News about the B-specific project at the ULEI website
News about the B-specific project at the ULEI website
Preventing heart attacks by earlier detection of cardiovascular disease